Trials / Terminated
TerminatedNCT00527046
Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults
A Randomized, Double Blind, Placebo Controlled, Five Parallel Group Study Of The Effect Of CP-424,391 On Physical Performance And Body Composition In Older Subjects
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 396 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 65 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
A 24-month, placebo controlled, double dummy, parallel-design outpatient trial in generally healthy elderly men and women who are at risk of becoming frail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CP-424,391 |
Timeline
- Start date
- 1999-12-01
- Primary completion
- 2001-10-01
- Completion
- 2001-10-01
- First posted
- 2007-09-10
- Last updated
- 2012-02-02
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00527046. Inclusion in this directory is not an endorsement.